Skip to content
Shameless Cloning

Search Shameless Cloning

Search superinvestors, stocks, insiders and members of Congress

Q1 2026 13F · SEC CIK 1640801

Park Avenue Institutional Advisers LLC

Institutional asset managerFiled 2026-05-05 for Q1 2026. Open the filing ↗ · All SEC filings ↗

Reported 13F value
$199.2M
Reported positions
5
Holdings vs S&P 500, 3 yrs
—
Assets under management
$82.0B

Park Avenue Institutional Advisers LLC is an institutional asset manager that reported 5 positions worth $199.2M in its Q1 2026 13F, filed 2026-05-05. Its largest holdings were Janus Henderson Aa-A Clo ETF (JA, 50.1%), Janus Henderson Asset-Backed Securities (JABS, 49.4%), Revolution Medicines Inc (RVMD, 0.3%).

Park Avenue Institutional Advisers LLC holdings all 5 positions.

Weights are shares of the filer's total reported 13F value, compared with Q3 2024. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.

Park Avenue Institutional Advisers LLC 13F holdings
Stock% of 13F valueShare changeReported value
JAJanus Henderson Aa-A Clo ETF50.1%—$99.9M
JABSJanus Henderson Asset-Backed Securities 49.4%—$98.5M
RVMDRevolution Medicines Inc0.3%—$497K
BRZEBraze Inc0.1%—$210K
TTANServiceTitan, Inc.0.1%—$175K

What Park Avenue Institutional Advisers LLC bought and sold in Q1 2026, against Q3 2024.

Added to

No position grew by more than 5%.

Reduced

No position shrank by more than 5%.

Share counts compared with the Q3 2024 13F; a split also changes share counts.

How the holdings did against the S&P 500.

1 year
—
3 years
—
5 years
-2.5% /yr
S&P 500 +8.6%

A portfolio of the filer's 20 largest 13F positions, weighted by value and rebuilt each quarter on the day the filing became public. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.

Reported 13F value by quarter.

13F value by quarter
Quarter13F valuePositions
Q1 2026$199.2M5
Q3 2024$53.6M5
Q2 2024$67.2M5
Q1 2024$45.3M5
Q3 2023$38.6M5
Q2 2023$40.7M5
Q1 2023$74.0M8
Q4 2022$74.6M7
Q3 2022$77.0M7
Q2 2022$70.9M6
Q1 2022$119.3M8
Q4 2021$100.0M6

Questions about Park Avenue Institutional Advisers LLC's portfolio

What stocks does Park Avenue Institutional Advisers LLC own?

Park Avenue Institutional Advisers LLC's latest 13F, for Q1 2026 and filed May 5, 2026, lists 5 positions worth $199.2M. The largest are Janus Henderson Aa-A Clo ETF (JA) at 50.1%, Janus Henderson Asset-Backed Securities (JABS) at 49.4%, Revolution Medicines Inc (RVMD) at 0.3%, Braze Inc (BRZE) at 0.1% and ServiceTitan, Inc. (TTAN) at 0.1%.

What did Park Avenue Institutional Advisers LLC buy last quarter?

In Q1 2026, Park Avenue Institutional Advisers LLC added a new position in Janus Henderson Aa-A Clo ETF (JA), a new position in Janus Henderson Asset-Backed Securities (JABS), a new position in Revolution Medicines Inc (RVMD), a new position in Braze Inc (BRZE) and a new position in ServiceTitan, Inc. (TTAN), compared with its Q3 2024 filing.

What did Park Avenue Institutional Advisers LLC sell last quarter?

In Q1 2026, Park Avenue Institutional Advisers LLC sold all of Ishares Tr (MBB), sold all of Vmbs (VMBS), sold all of State Street Spdr Bloomberg High Yield B (JNK), sold all of Ishares Trust (HYG) and sold all of Ssga Active ETF Tr (SRLN), compared with its Q3 2024 filing.

When is Park Avenue Institutional Advisers LLC's next 13F filing due?

13F filings are due 45 days after each quarter ends. Park Avenue Institutional Advisers LLC's filing for the quarter ending Jun 30, 2026 was due by Aug 14, 2026; this page updates once it is processed.

How much money does Park Avenue Institutional Advisers LLC manage?

Park Avenue Institutional Advisers LLC reported $82.0B of regulatory assets under management on its latest SEC Form ADV. Its 13F, which covers only US-listed stocks and options, totals $199.2M.